Objective To investigate the short term efficacy of transcatheter arterial chemoem-bolization (TACE) combined with arsenic trioxide (AS2O3) in the treatment of primary liver cancer. Methods Thirty-two patients with advanced primary liver cancer underwent routine hepatic arterial chemoembolization, repeated every 4 weeks for 2 to 3 cycles. In each cycle of chemoembolization, AS2O3 were injected intravenously once a day for 2 weeks at a dose of 10~15 mg. Results All patients completed 2-3 cycles treatment and...